Corporate & Background
 Custom Manufacturing
 Business & Products
 Facilities & Strengths
 Ethics & Values
 Regulatory Submissions
 Investors & Financials
 Sustainability
 Careers
 Locations & Contact
 Media Center
 Enquiry
 Home
      News & Events


 Divi's Labs earns an Income of Rs.366 crores in Q2 of FY12
  Divi's Labs earns a PBT of Rs. 130 crores for Q1 of FY12
  Divi's Labs PAT for Q4 grew by 36% to Rs.175 crores
  Divi's Labs earns an Income of Rs.313 crores for Q3 of FY11
  Divi's Labs earns an Income of Rs.265 crores in Q1
  Divi's Labs earns a PAT of Rs.129 crores for Q4
  Divi's Labs earns an Income of Rs.649 crores for 9M of FY10
  Divi's Labs earns an Income of Rs.445 crores in H1 of FY10
  Divi's Labs earns a PAT of Rs.417 for the year 2008-09 And declares 1:1 bonus
  Divi's Labs PAT for 9 months
grows by 21% to Rs.309 crores
  Divi's Labs PAT for Q2 grows by
49% to Rs.135 crores
  Divi's Labs PAT for Q1 grows by
45% to Rs.94 crores
  Divi's Labs PAT for FY08 grows by 87% to Rs.348 crores
  Divi's Labs PAT for Q3 grows by 216% to Rs.99 crores
  Divi's Labs PAT for Q2 grows by 204% to Rs.91 crores
  Divi's Labs PAT for Q1 grows by 153% to Rs.65 crores
  Divi's Labs PAT for FY07
grows by 167% to Rs.186 crores
  Divi's Labs Q3 total income
 grows by 38% to Rs.152 crores
 Divis successful US-FDA inspection for Unit II
  Divi's Labs Q2 total income
 grows by 97% to Rs.165 crores.
  Divi's Labs Q1 total
 income grows by 142% at
 Rs.165 crores
  Divi's Laboratories earns a
 Net of Rs.19 crores
 on an Income of
 Rs.110 Crores in Q3
 Divis labs SEZs cleared
  Divis Laboratories earns a
 PBT of Rs.43 Crores in
 First-Half of FY06
  Divis Laboratories earns a
 total income of Rs.68
 Crores in Q1 of FY06
  Divis Laboratories earns a
 total income of Rs.365
 Crores in FY05
  Divis Laboratories earns a
 Net of Rs.105 Crores in Q3
  Divis Laboratories earns a
 PBT of Rs.45 Crores in
 First-Half of FY05
  Divis Laboratories earns a
 Net of Rs.14 Crores in Q1
Drug Master Files Submitted to the US FDA

S.No

Name of the Compound

Date of Submission

DMF Number

01

Dextromethorphan HBr

04-Feb-1997

12,356

02

Naproxen

27-Nov-1998

13,866

03

Naproxen Sodium

27-Nov-1998

13,867

04

Diltiazem HCl

26-Jan-2001

15,267

05

Nabumetone

02-Apr-2001

15,364

06

Levetiracetam

05-Oct-2003

16,894

07

Phenylephrine HCl

19-Oct-2003

16,918

08

Loratadine

07-Nov-2004

17,810

09

Carbidopa

20-Nov-2004

17,846

10

Levodopa

03-Dec-2004

17,874

11

Proguanil HCl

06-Feb-2005

18,065

12

Iopamidol

06-Feb-2005

18,066

13

Bupropion HCl

24-Apr-2005

18,306

14

Niacin

05-Jul-2005

18,481

15

Verapamil HCl

17-Jul-2005

18,523

16

Fosphenytoin Sodium

25-Sep-2005

18,806

17

Zolpidem Tartrate

25-Sep-2005

18,808

18

Risedronate Sodium

25, Sep-2005

18,807

19

Tamsulosin HCl

25-Nov-2005

18,971

20

Gabapentin

04-Dec-2005

19,000

21

Desloratadine

17-May-2006

19,441

22

Sibutramine HCl

04-Sep-2006

19,729

23

Quetiapine Fumarate

25-Oct-2007

20,983

24

Vigabatrin

29-Apr-2008

21,579

25

Ketoenamine

05-Oct-2008

22,065

26

Capecitabine

27-Oct-2008

22,157

27

Dextromethorphan Base

28-Jan-2009

22,469

28

Venlafaxine HCl

28-Jan-2009

22,470

29

Sumatriptan and Sumatriptan Succinate

10-Mar-2010

23,624

30

Valsartan

08-Apr-2011

24,797


CoS Submissions to EDQM

S.No

Name of the Compound

Certificate Issued on

CEP Number

01

Naproxen

03-Sep-2008

R1-CEP 1999-042-Rev 04

02

Dextromethorphan HBr

18-Jul-2007

R1-CEP 1999-103-Rev 01

03

Nabumetone

06-Nov-2008

R1-CEP 1999-055-Rev 01

04

Diltiazem HCl

19-Jan-2009

R1-CEP 1999-156-Rev 02

05

Carbidopa

02-Oct-2006

RO-CEP 2005-057-Rev 01

06

Levodopa

29-Jun-2007

R0-CEP 2005-161-Rev 01

07

Phenylephrine HCl

20-Apr-2007

R0-CEP 2005-291-Rev 01

08

Iopamidol

11-Apr-2007

R0-CEP 2006-038-Rev 01

09

Zolpidem Tartrate

17-Oct-2008

R0-CEP 2006-105-Rev 00

10

Naproxen Sodium

10-Oct-2008

R0-CEP 2007-110-Rev 00


European Drug Master Files

S.No

Name of the Compound

Submitted to

Submitted on

DMF number

01

Naproxen Sodium

AEMPS, Spain [Updated copy submitted]

21-Apr-2008

NS/893/02

02

Zolpidem Tartrate

MEB, The Netherlands

25-Apr-2006

1378

03

Zolpidem Tartrate

TGA, Australia

25-Apr-2006

2006/26062

04

Gabapentin

AFSSAPS, France

31-Mar-2010

Yet to be received

05

Naproxen Sodium

AIFA, Italy

18-Jun-2005

Yet to be received

06

Naproxen Sodium

Directorate General for Medicinal products, Belgium

22-Jul-2005

1064

07

Carbidopa

MInistry of Health, Cyprus

17-Aug-2006

2006-DMF-510

08

Sibutramine HCl

AEMPS, Spain

24-Dec-2006

SE-1883-06

09

Sibutramine HCl

Romania

24-Dec-2006

03

10

Sibutramine HCl

INFARMED, Portugal

24-Dec-2006

16/2007

11

Sibutramine HCl

MEB, The Netherlands

24-Dec-2006

1493

12

Gabapentin

Finland

10-Jul-2007

001

13

Sibutramine HCl

IMB, Ireland

04-Oct-2007

13420002

14

Zolpidem Tartrate

Iceland

12-Dec-2007

DMF-IS-597

15

Zolpidem Tartrate

Poland

19-Dec-2007

PL/DC-4003-0103/08

16

Zolpidem Tartrate

Czech Republic

19-Dec-2007

SUKLS 91/2008

17

Zolpidem Tartrate

AIFA, Italy

19-Dec-2007

Yet to be received

18

Zolpidem Tartrate

United Kingdom

19-Dec-2007

MFD-15298-2-08037-0001

19

Zolpidem Tartrate

Belgium

19-Dec-2007

1418

20

Zolpidem Tartrate

Luxembourg

19-Dec-2007

Yet to be received

21

Zolpidem Tartrate

ZEMPS, Spain

19-Dec-2007

Yet to be received

22

Quetiapine Fumarate

OGYI, Hungary

18-Jan-2008

3728/80/08

23

Quetiapine Fumarate

MHRA,UK

29-Jan-2008

MFD-15298-2-05649-0001

24

Naproxen Sodium

Poland

19-Jan-2008

PL/DC-4003-0103/08

25

Levetiracetam

TGA, Australia

05-Mar-2008

2008/2460

26

Gabapentin

Ministry of Health, Cyprus

13-Oct-2008

Yet to be received

27

Dextromethorphan Base

Swismedic, Switzerland

15-Apr-2008

D1448

28

Gabapentin

MHRA,UK

06-Jun-2008

MFD-15298-1-07380-0001

29

Gabapentin

Australia

19-Sep-2008

2008/8808

30

Rizatriptan Benzoate

Netherlands

15-Sep-2008

77106

31

Rizatriptan Benzoate

Norway

15-Sep-2008

08/13333

32

Rizatriptan Benzoate

Sweden

15-Sep-2008

Dnr 116: 2008/73790

33

Rizatriptan Benzoate

Spain

04-Nov-2008

RB/2245/08

34

Rizatriptan Benzoate

Italy

27-Sep-2008

Yet to be received

35

Rizatriptan Benzoate

Finland

27-Aug-2008

001/2008-08-27

36

Rizatriptan Benzoate

Luxembourg

27-Sep-2008

Yet to be received

37

Rizatriptan Benzoate

Germany

10-Sep-2008

2122

38

Rizatriptan Benzoate

MHRA, UK

29-Sep-2008

MFD-15298-2-07163-0001

39

Rizatriptan Benzoate

Denmark

29-Sep-2008

2215 ? 1434

40

Levetiracetam

Croatia

19-Dec-2008

381-08-37097-1
530-09/08-09/04

41

Dextromethorphan Base

INFARMED,Portugal [Updated copy submitted]

8-May-2009

Yet to be received

42

Dextromethorphan Base

Spain

8-May-2009

Yet to be received

43

Proguanil.HCl

MHRA,UK

17-Jul-2009

MFD-15298-2-08310-0001

44

Proguanil.HCl

Germany

22- Jul-2009

2346

45

Proguanil.HCl

France

24-Sep-2009

2009-128

46

Proguanil.HCl

Netherlands

10- Jul-2009

Yet to be received

47

Proguanil.HCl

Denmark

5-Aug-2009

2215-1605

48

Quetiapine Fumarate

Australia

24- Jul-2009

Yet to be received

49

Dextromethorphan Base

Spain

08-Sep-2009

DB/2528/09

50

Dextromethorphan Base

Germany

12-Nov-2009

2430

51

Dextromethorphan Base

UK

08-Dec-2009

MFD-15298-1-03241-0001

52

Triprolidine.HCl

Belgium

27-Jan- 2010

1606

53

Triprolidine HCl

Cyprus

02-Mar-2010

2010-DMF-944

54

Levetiracetam

France

02-Nov-2009

2009-213

55

Dextromethorphan Base

TGA

03-Dec-2009

2009/011929

56

Gabapentin

Greece

08-Mar-2010

2365

57

Gabapentin

Austria

16-Mar-2010

10057

58

Gabapentin

Germany

16-Mar-2010

2505

59

Gabapentin

Czech Republic

25-Mar-2010

27824/10

60

Gabapentin

Denmark

16-Apr-2010

2215-1712

61

Gabapentin

Sweden

18-Mar-2010

Dnr 116:2010/507516

62

Gabapentin

Italy

02-Apr-2010

Yet to be received

63

Gabapentin

Poland

25-Feb-2010

Yet to be received

64

Gabapentin

Portugal

09-Jun-2010

Yet to be received

65

Gabapentin

Spain

03-Jun-2010

Yet to be received

66

Gabapentin

MHRA

12-July-2010

Yet to be received

67

Gabapentin

Belgium

06-July-2010

105470

68

Dextromethorphan Base

France

07-July-2010

Yet to be received

69

Dextromethorphan Base

Belgium

07-July-2010

Yet to be received

70

Dextromethorphan Base

Hungary

12-July-2010

Yet to be received

71

Dextromethorphan Base

Czech republic

07-July-2010

Yet to be received

72

Dextromethorphan Base

Poland

12-July-2010

Yet to be received


Drug Master Files Submitted to HEALTH CANADA

S.No

Name of the Compound

Date of Submission

DMF Number

01

Levetiracetam

20-Dec-2004

2005-091

02

Proguanil HCl

19-Jan-2005

2005-036

03

Dextromethorphan HBr

19-Jul-2005

2005-146

04

Tamsulosin HCl

29-Aug-2006

2006-141

05

Naproxen

30-Aug-2007

2007-202

06

Carbidopa

26-Sep-2007

2007-198

07

Naproxen Sodium

13-Feb-2008

2008-032

08

Rizatriptan Benzoate

27-Sep-2008

2008-212

09

Ketoenamine

01-Oct-2008

2008-216

10

Levodopa

07-Mar-2009

2009-062

11

Desloratadine

31-Jul-2009

2009-168

12

Triprolidine hydrochloride

12-Jun-2010

Yet to be received

13

Sumatriptan

15-Oct-2010

2010-220

14

Sumatriptan Succinate

15-Oct-2010

2010-219

15

Diltiazem Hydrochloride

06-Jan-2011

2010-279


KDMFs Submitted to the Korea FDA

S.No

Product Name

DMF submitted on

DMF number

01

Nabumetone

28-Jul-2004

1764

02

Phenylephrine HCl

19-Jan-2007

20070022981




SDA - China submissions

S.No

Name of the Compound

IDL Issued Date

Drug License Number

01

Diltiazem hydrochloride

31-Dec-2003

H20030689

02

Dextromethorphan HBr

18-Nov-2005

H20050543



DMFs Submitted to the Japan PMDA (Pharmaceutical and Medical Devices Agency)

S.No

Name of the Compound

Date of Submission

DMF Number

01

Dextromethorphan HBr

29-Dec-2006

217MF10567

02

Zolpidem Tartrate

18-Jan-2007

219MF10009

03

Dextromethorphan Base

28-Aug-2008

220MF10194

04

Gabapentin

16-Nov-2009

221MF10243

top
top
Copyright © 2006, Divis Laboratories Ltd. All Rights Reserved     Web design london